Latest / European Society for Vascular Surgery
TEVAR vs Standard Medical Therapy in Uncomplicated Type B Aortic Dissection: A Roundtable with the IMPROVE-AD, EARNEST and SUNDAY Trial Investigators
Three trials walk into an aorta and ask what the house recommends. The bartender shrugs: “Sorry, we’re randomising tonight.”
Three trials. Three leading investigators. One of the biggest unresolved questions in aortic surgery: should patients with uncomplicated type B aortic dissection undergo thoracic endovascular aortic repair (TEVAR), or is best medical therapy the better strategy?
In this episode of the ESVS Podcast, Safa Riahi brings together Professor Jacob Budtz-Lilly (SUNDAY), Professor Firas Mussa (IMPROVE-AD) and Professor Colin Bicknell (EARNEST), for an in-depth roundtable…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.